Magenta Medical vs Revvity
Side-by-side comparison of AI visibility scores, market position, and capabilities
Magenta Medical is developing the Elevate pLVAD, the world's smallest percutaneous heart pump — FDA Breakthrough Device for HR-PCI and cardiogenic shock; raised $105M Series C in 2023.
About
Magenta Medical is an Israel-based medical device company developing a miniaturized percutaneous Left Ventricular Assist Device (pLVAD) to provide temporary mechanical circulatory support for patients with acute cardiac conditions. Founded and headquartered in Israel, the company''s flagship product, the Elevate™ heart pump, is inserted via an 8-French catheter over a guidewire — making it one of the least invasive cardiac support devices ever developed. It can deliver more than 5 L/min of hemodynamic support.
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
About
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.